FDA inspection
Swati Spentose Private Limited: FDA inspection ending Dec 12, 2018
FDA inspection 1076313 · Voluntary Action Indicated (VAI) · Vapi
Key facts
| Inspection ID | 1076313 |
|---|---|
| Firm | Swati Spentose Private Limited |
| FEI number | 3009765202 |
| Address | Plot No A-1/2102, 2103, Phase Iii, Gidc |
| City | Vapi |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Dec 12, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data